Centre Henri Becquerel / Centre Regional de Lutte Contre le Cancer

Rouen 76038

0 studies enrolling now · 3 studies all time

What they study most

Anaplastic Large-Cell Lymphoma, Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Cutaneous, Non-Hodgkin Lymphoma, T-Cell Lymphoma

Studies at this site

• ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas — Completed
• A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial) — Completed
• A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001 — NO_LONGER_AVAILABLE